Boceprevir Plus Peginterferon α-2b/Ribavirin in Chronic Hepatitis C Genotype 1-Reference-Cited by-同舟云学术

Boceprevir Plus Peginterferon α-2b/Ribavirin in Chronic Hepatitis C Genotype 1

Published:2014-05 Issue:5 Volume:48 Page:435-443
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Gordon Stuart C.,Reddy K. Rajender,Jacobson Ira M.,Poordad Fred,Bronowicki Jean-Pierre,Bacon Bruce,Buti Maria,Hu Ke-Qin,Pedicone Lisa D.,Burroughs Margaret,Brass Clifford A.,Albrecht Janice K.,Lawitz Eric J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference3 articles.

1. Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.;Ticehurst;J Clin Microbiol,2007

2. Correlation between insulin resistance and hepatitis C viral load.;Harrison;Hepatology,2006

3. A 48-week duration of therapy with pegylated interferon 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus.;Drusano;J Infect Dis,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus and Hepatocellular Cancer: Molecular Mechanisms and Advancements in Treatment;Pathogens Associated with the Development of Cancer in Humans;2024

2. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives;Current Issues in Molecular Biology;2023-10-11

3. Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China;Hepatitis Monthly;2015-06-23

4. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients;HIV Medicine;2014-06-04